Low-Dose Levothyroxine Reduces Intrahepatic Lipid Content in Patients With Type 2 Diabetes Mellitus and NAFLD
Eveline Bruinstroop, Rinkoo Dalan, Yang Cao, Yong Mong Bee, Kurumbian Chandran, Li Wei Cho, Shui Boon Soh, Eng Kiong Teo, Sue-Anne Toh, Melvin Khee Shing Leow, Rohit A Sinha, Suresh Anand Sadananthan, Navin Michael, Heather M Stapleton, Christopher Leung, Peter W Angus, Sheila K Patel, Louise M Burrell, Su Chi Lim, Chee Fang Sum Show all
The Journal of Clinical Endocrinology & Metabolism | ENDOCRINE SOC | Published : 2018
Awarded by National Health and Medical Research Council of Australia
Awarded by Catherine van Tussenbroekfonds
The animal research was supported by a National Health and Medical Research Council of Australia Grant and scholarship [1029990 (to P.W.A. and C.L.) and 629025 (to C.L.)]. The human intervention study was sponsored by the Tanoto Initiative for Diabetes Research (to P.M.Y.). E.B. was funded by a Niels Stensen Fellowship, Ter Meulen Grant of the Royal Netherlands Academy of Arts and Sciences, and Catherine van Tussenbroekfonds (A3-2; www.evtfonds.nl).